📰 Clinical Developments News
Clinical Developments News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Developments. Real-time updates on events, politics, business and more.
May 11, 2023
SOUTH SAN FRANCISCO, Calif., May 11, 2023 -- ALX Oncology Holdings Inc., , a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today reported... | May 11, 2023
February 15, 2023
/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing protein kinase...
March 9, 2022
/PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,...
March 9, 2022
/PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,...
January 13, 2021
Share this article Share this article ResearchAndMarkets.coms offering. The global market for antibiotics should grow from $44.4 billion in 2020 to reach $65.4 billion by 2025 at a compound annual growth rate (CAGR) of 8.1% during the period of 2020-2025. The report focuses on newer drugs and innovations in chemical compounds, vaccines and biologicals, recently launched or in development. Specifically excluded from the scope of research are vector or mosquito control approaches, strategies and ...
January 12, 2021
Antibiotics Technologies and Markets, 2025 January 12, 2021 04:38 ET | Source: Research and Markets Research and Markets Dublin, IRELAND Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "Antibiotics: Technologies and Global Markets" report has been added to ResearchAndMarkets.coms offering. The global market for antibiotics should grow from $44.4 billion in 2020 to reach $65.4 billion by 2025 at a compound annual growth rate (CAGR) of 8.1% during th...